Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 3173 of 3173 entries
View as:

Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00676143 Org: User:
Start: 01/31/08 End: 11/30/12 Due: 11/30/13

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT05070845 Org: User:
Start: 02/02/22 End: 10/01/27 Due: 10/01/28

Study Evaluating Bapineuzumab In Alzheimer Disease Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00663026 Org: User:
Start: 11/30/08 End: 10/31/10 Due: 10/31/11

A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03612557 Org: User:
Start: 08/20/18 End: 10/02/18 Due: 10/02/19

A Study Comparing Drug Availability Of Methylprednisolone In Liquid Form Versus Methylprednisolone In Tablet Form

Phase: N/A Priority: Normal
NCT ID: NCT01267201 Org: User:
Start: 11/30/10 End: 12/31/10 Due: 12/31/11

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Phase: N/A Priority: Normal
NCT ID: NCT00932451 Org: User:
Start: 01/31/10 End: 12/31/15 Due: 12/31/16

Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib

Phase: N/A Priority: Normal
NCT ID: NCT00474786 Org: User:
Start: 09/30/07 End: 01/31/13 Due: 01/31/14

Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice

Phase: N/A Priority: Normal
NCT ID: NCT01793142 Org: User:
Start: 10/24/13 End: 05/31/17 Due: 05/31/18

Drug Interaction Study Between Bosutinib And Dabigatran

Phase: N/A Priority: Normal
NCT ID: NCT02102633 Org: User:
Start: 05/31/14 End: 06/30/14 Due: 06/30/15

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

Phase: N/A Priority: Normal
NCT ID: NCT01574703 Org: User:
Start: 05/31/12 End: 07/31/15 Due: 07/31/16

Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.

Phase: N/A Priority: Normal
NCT ID: NCT05069259 Org: User:
Start: 03/28/22 End: 04/30/24 Due: 04/30/25

Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD

Phase: N/A Priority: Normal
NCT ID: NCT04247594 Org: User:
Start: 01/09/20 End: 06/08/21 Due: 06/08/22

A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India

Phase: N/A Priority: Normal
NCT ID: NCT06086353 Org: User:
Start: 03/25/24 End: 04/30/25 Due: 04/30/26

Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT06412965 Org: User:
Start: 01/02/24 End: 01/03/24 Due: 01/03/25

A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

Phase: N/A Priority: Normal
NCT ID: NCT02546375 Org: User:
Start: 07/15/15 End: 01/16/17 Due: 01/16/18

Cumulative Irritation Test

Phase: N/A Priority: Normal
NCT ID: NCT00680095 Org: User:
Start: 01/22/07 End: 02/19/07 Due: 02/19/08

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00987337 Org: User:
Start: 11/30/09 End: 01/31/12 Due: 01/31/13

Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT00484185 Org: User:
Start: 08/31/07 End: 06/30/12 Due: 06/30/13

A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause

Phase: N/A Priority: Normal
NCT ID: NCT06465368 Org: User:
Start: 07/11/24 End: 10/24/25 Due: 10/24/26

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05788328 Org: User:
Start: 03/27/23 End: 09/11/23 Due: 09/11/24

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

Phase: N/A Priority: Normal
NCT ID: NCT06703606 Org: User:
Start: 05/13/25 End: 05/23/31 Due: 05/23/32

Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures

Phase: N/A Priority: Normal
NCT ID: NCT00143442 Org: User:
Start: 12/31/03 End: 10/31/04 Due: 10/31/05

Lorlatinib Continuation Study

Phase: N/A Priority: Normal
NCT ID: NCT05144997 Org: User:
Start: 12/28/21 End: 12/28/26 Due: 12/28/27